Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amedisys Inc (NQ: AMED )

90.94 -0.02 (-0.02%)
Streaming Delayed Price Updated: 3:16 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Amedisys Inc

< Previous 1 2 3 4 Next >
Amedisys: Q4 Earnings Insights
Amedisys (NASDAQ:AMED) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
The U.S. Home Health Care Industry Is Reportedly Booming As Seniors Overwhelmingly Want To Live At Home
Photo by Kampus Production from Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice... 
Via Benzinga
This Company Just Made a Possibly Lucrative Acquisition — What's Next?
Photo by Ccfb on Pixabay This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The global... 
Via Benzinga
10 Bargain Stocks to Buy After Falling 30% in 2021
If you’re looking for bargain stocks to buy that are down 30% or more in 2021, that’s not an easy task. Here are 10 that fit the bill. 
Via InvestorPlace
This Home Medical Company Looks to Be Moving Fast — What's Next?
Photo by National Cancer Institute on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a... 
Via Benzinga
Analyst Ratings For Amedisys
Over the past 3 months, 11 analysts have published their opinion on Amedisys (NASDAQ: 
Via Benzinga
Analyst Ratings For Amedisys
Within the last quarter, Amedisys (NASDAQ:AMED) has observed the following ... 
Via Benzinga
Best Undervalued Health Care Companies You Never Heard Of
Health care is a gigantic industry and global spending is expected to rise at a 3.9% compound annual growth rate by 2024. Here are three health care stocks that look interesting. 
Via Talk Markets
This Industry, Important for Quality of Life, Is Big Business
Photo by Hush Naidoo Jade Photography on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a... 
Via Benzinga
What 12 Analyst Ratings Have To Say About Amedisys
Amedisys (NASDAQ:AMED) has observed the following analyst ratings within t... 
Via Benzinga
Amedisys, inc (AMED) Q3 2021 Earnings Call Transcript
AMED earnings call for the period ending October 2, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Price Over Earnings Overview: Amedisys
Right now, Amedisys Inc. (NASDAQ:AMED) share price is at $168.88, after a 1.22% drop. Over the past month, the stock went up by 16.83%, but over the past year, it... 
Via Benzinga
Analyst Ratings For Amedisys
Within the last quarter, Amedisys (NASDAQ:AMED) has observed the following... 
Via Benzinga
Where Amedisys Stands With Analysts
Within the last quarter, Amedisys (NASDAQ:AMED) has observed the following ... 
Via Benzinga
Where Amedisys Stands With Analysts
Within the last quarter, Amedisys (NASDAQ:AMED) has observed the following ... 
Via Benzinga
Analyst Ratings For Amedisys
Over the past 3 months, 6 analysts have published their opinion on Amedisys (NASDAQ: 
Via Benzinga
What 9 Analyst Ratings Have To Say About Amedisys
Amedisys (NASDAQ:AMED) has observed the following analyst ratings within t... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021
Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ: 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Before 10 a.m. ET on Monday, 29 stocks hit new 52-week lows. Significant Points: The largest company by market cap to set a new 52-week low was Alibaba Group... 
Via Benzinga
What 6 Analyst Ratings Have To Say About Amedisys
Within the last quarter, Amedisys (NASDAQ:AMED) has obser... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
Upgrades Berenberg upgraded the previous rating for Tenable Holdings Inc (NASDAQ: 
Via Benzinga
Return on Capital Employed Overview: Amedisys
After pulling data from Benzinga Pro it seems like during Q2, Amedisys (NASDAQ:AMED) earned $78.14 million, a 13.49% increase from the preceding quarter. Amedisys also posted a... 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Rosenblatt raised the price target on The Trade Desk, Inc. (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021
Upgrades According to JonesTrading, the prior rating for Orchid Island Capital Inc (NYSE: 
Via Benzinga
Amedisys, inc (AMED) Q2 2021 Earnings Call Transcript
AMED earnings call for the period ending July 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nautilus Biotechnology (NASDAQ:NAUT) stock rose 25.23% to $9.38 during Thursday's regular session. Nautilus Biotechnology's stock is trading at a volume of... 
Via Benzinga
99 Biggest Movers From Yesterday
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... 
Via Benzinga
Why Amedisys Stock Is Crashing Today
The company provided disappointing full-year guidance. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021
Upgrades Stephens & Co. upgraded the previous rating for Roku Inc (NASDAQ: 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 77 companies made new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.